Skip to content

GeneDx Holdings WGS Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$77.81M-270%-$21.02M
$26.36M+4.5%$25.22M+5.5%$23.9M+2.3%$23.36M+4.3%$22.38M+2.0%
$37.18M+15.6%$32.16M+27.5%$25.23M+38.0%$18.28M+34.7%$13.57M+48.5%
-$6.22M-117%$36.37M+9.6%$33.19M+155%$13.02M+785%-$1.9M+93.3%
$19.34M+1.7%$19.02M+7.3%$17.72M+45.3%$12.19M+9.1%$11.18M+104%
-$69.36M-12.8%-$61.52M-20.7%-$50.96M+5.7%-$54.03M-33.8%-$40.38M-34.0%
$72.9M+51.8%$48.03M-14.0%$55.86M-5.4%$59.06M+1.3%$58.32M+32.1%
-$5.78M-129%$19.79M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does GeneDx Holdings's cash flow data come from?
Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.